insights_auto
Why is 603259 down ६.६०%?
Dive Deeperchevron_right
603259:SHA
WuXi AppTec Co Ltd
CN¥ १४४.३०
arrow_downward
-६.६०%(-१०.२०) 1D
अक्टोबर १६, १५:००:०१ GMT+८ · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 603259...
Open
CN¥ १५६.९४
High
CN¥ १५९.९२
Low
CN¥ १३९.०५
Mkt. cap
४.४७ खरब
Avg. vol.
३.४० करोड
Volume
८.३६ करोड
Dividend
१.४५%
Quarterly dividend
CN¥ ०.५२
Ex-dividend date
२०२६ सेप्टेम्बर ४
P/E ratio
१९.६३
52-wk high
CN¥ १७३.६०
52-wk low
CN¥ ८७.०९
EPS
CN¥ ७.३५
Shares outstanding
१.०५ अरब
No. of employees
३६ हजार
Open
CN¥ १५६.९४
High
CN¥ १५९.९२
Low
CN¥ १३९.०५
Mkt. cap
४.४७ खरब
Avg. vol.
३.४० करोड
Volume
८.३६ करोड
Dividend
१.४५%
Quarterly dividend
CN¥ ०.५२
Ex-dividend date
२०२६ सेप्टेम्बर ४
P/E ratio
१९.६३
52-wk high
CN¥ १७३.६०
52-wk low
CN¥ ८७.०९
EPS
CN¥ ७.३५
Shares outstanding
१.०५ अरब
No. of employees
३६ हजार
News stories
From web sources and news partners
ad-hoc-news.de
·
१ दिन पहिले
Morgan Stanley keeps target for WuXi AppTec stock at HKD 207.40
ad-hoc-news.de
·
२ दिन पहिले
Morgan Stanley backs 800-ton expansion for WuXi AppTec stock
Profile
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
About WuXi AppTec Co Ltd
CEOSteve Yang | Ge Li
Employees३५.६ हजार
Founded२००० डिसेम्बर १
Headquarters-
Sector-
Websitewuxiapptec.com.cn